Researchers at the University of Oklahoma have made a discovery that could potentially revolutionize treatments for ...

The dipeptidyl peptidase 1 (DPP-1) inhibitor cut the annualized rate of pulmonary exacerbations by around 20% compared with ...

Game-changing substance could transform infection control for hospitals and health clinics In a nutshell Researchers have ...

PHAXIAM Therapeutics (Euronext: PHXM - FR001400K4B1), a biopharmaceutical company ("the Company" or "PHAXIAM") developing innovative treatments for severe and resistant bacterial infections, announces ...

Researchers have made a breakthrough discovery that could potentially revolutionize treatments for antibiotic-resistant infections, cancer and other challenging gram-negative pathogens without relying ...

Researchers at the University of Oklahoma have made a breakthrough discovery that could potentially revolutionize treatments for antibiotic-resistant ...

The results from two newly published randomized clinical trials provide more evidence that a computerized stewardship alert ...

Biliary tract infections (BTI), often linked to structural abnormalities like bile duct stones, pose significant treatment challenges due to drug-resistant bacteria like Pseudomonas aeruginosa. Phage ...